Fund Product, Company and Regulatory Updates as at 9 October 2018

  • Fidelity launches global emerging markets ETF

  • AMP cans SMSF lending, divests $440m from tobacco

  • Tobacco exclusion indices launched by MSCI

  • Bill introduced for revealing target markets of financial products

  • SMSF lending proposal from ASIC

  • New fintech agreements signed between Australia and US, Luxembourg

Read More

Risk Product, Company and Regulatory Updates as at 2 October 2018

  • Asteron Life Complete product changes

  • Zurich launches new adviser portal

  • MetLife Australia back in retail life business

  • ASIC taking civil action against ANZ

  • ASIC report finds unacceptable delays in reporting by institutions

  • Dover Financial Advisers and sole director taken to court

  • FASEA announces changes to qualification requirements for advisers

  • NAB and MLC facing class action over consumer credit insurance

Read More

Fund Product, Company and Regulatory Updates as at 25 September 2018

  • Uni students running hedge fund

  • Class actions planned against retail super funds

  • IOOF sells AET

  • Combined Super to merge with Prime Super

  • ASIC commencing civil proceedings against ANZ

  • ASIC updates regulatory approvals for new products and ETFs of the Chi-X market

  • ASIC stops proposed initial coin offerings

Read More

Risk Product, Company and Regulatory Updates as at 18 September 2018

  • AMP updates medical definitions

  • AIA Australia two year policy fee waiver offer

  • OnePath premium waivers for drought-affected farmers

  • New fintech to replace paraplanners launched

  • Junior financial adviser roles at BT to go, advice restructure

  • Morgan Stanley false claims of independence

  • ASIC commences proceedings against NULIS and MLC

  • AFCA complaints resolution rules, independent assessor terms approved

  • FASEA shutting down so-called FASEA-approved courses

Read More